These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28981753)

  • 21. Stability assessment on a library scale: a rapid method for the evaluation of the commutability and insertion of residues in C-terminal loops of the CH3 domains of IgG1-Fc.
    Hasenhindl C; Traxlmayr MW; Wozniak-Knopp G; Jones PC; Stadlmayr G; Rüker F; Obinger C
    Protein Eng Des Sel; 2013 Oct; 26(10):675-82. PubMed ID: 24006374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
    Davis JH; Aperlo C; Li Y; Kurosawa E; Lan Y; Lo KM; Huston JS
    Protein Eng Des Sel; 2010 Apr; 23(4):195-202. PubMed ID: 20299542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A C-terminal interdomain disulfide bond significantly stabilizes the Fc fragment of IgG.
    Wozniak-Knopp G; Rüker F
    Arch Biochem Biophys; 2012 Oct; 526(2):181-7. PubMed ID: 22483683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast.
    Traxlmayr MW; Faissner M; Stadlmayr G; Hasenhindl C; Antes B; Rüker F; Obinger C
    Biochim Biophys Acta; 2012 Apr; 1824(4):542-9. PubMed ID: 22285845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
    Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys.
    Ren X; Li J; Xu X; Wang C; Cheng Y
    Exp Eye Res; 2016 Apr; 145():352-358. PubMed ID: 26919788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of Fcabs.
    Lai B; Hasenhindl C; Obinger C; Oostenbrink C
    Int J Mol Sci; 2014 Jan; 15(1):438-55. PubMed ID: 24451126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and Biological Evaluation of Fc Antigen Binding Fragment-Drug Conjugates as a Novel Antibody-Based Format for Targeted Drug Delivery.
    Jäger S; Wagner TR; Rasche N; Kolmar H; Hecht S; Schröter C
    Bioconjug Chem; 2021 Aug; 32(8):1699-1710. PubMed ID: 34185508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.
    Yu X; Qu L; Bigner DD; Chandramohan V
    Protein Eng Des Sel; 2017 Sep; 30(9):639-647. PubMed ID: 28981720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.
    Checco JW; Kreitler DF; Thomas NC; Belair DG; Rettko NJ; Murphy WL; Forest KT; Gellman SH
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4552-7. PubMed ID: 25825775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.
    Li D; Gong R; Zheng J; Chen X; Dimitrov DS; Zhao Q
    Biochem Biophys Res Commun; 2017 Apr; 485(2):446-453. PubMed ID: 28202413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B Cell-Based Seamless Engineering of Antibody Fc Domains.
    Hashimoto K; Kurosawa K; Murayama A; Seo H; Ohta K
    PLoS One; 2016; 11(12):e0167232. PubMed ID: 27907066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics.
    Schoch A; Kettenberger H; Mundigl O; Winter G; Engert J; Heinrich J; Emrich T
    Proc Natl Acad Sci U S A; 2015 May; 112(19):5997-6002. PubMed ID: 25918417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the Fc fragment of the NIST reference antibody RM8671.
    Gallagher DT; Galvin CV; Karageorgos I
    Acta Crystallogr F Struct Biol Commun; 2018 Sep; 74(Pt 9):524-529. PubMed ID: 30198883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heterodimeric Fc-based bispecific antibody simultaneously targeting VEGFR-2 and Met exhibits potent antitumor activity.
    Choi HJ; Kim YJ; Lee S; Kim YS
    Mol Cancer Ther; 2013 Dec; 12(12):2748-59. PubMed ID: 24132142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics.
    Everett KL; Kraman M; Wollerton FPG; Zimarino C; Kmiecik K; Gaspar M; Pechouckova S; Allen NL; Doody JF; Tuna M
    Methods; 2019 Feb; 154():60-69. PubMed ID: 30208333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review.
    Fonseca MHG; Furtado GP; Bezerra MRL; Pontes LQ; Fernandes CFC
    Int J Biol Macromol; 2018 Nov; 119():306-311. PubMed ID: 30041038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.
    Jendeberg L; Tashiro M; Tejero R; Lyons BA; Uhlén M; Montelione GT; Nilsson B
    Biochemistry; 1996 Jan; 35(1):22-31. PubMed ID: 8555177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.